Under the slogan #WeStopThisVirusTogether, workers at DS Smith's plant in Madrid have looked to play their part by manufacturing cardboard furniture. Madrid, 14 April 2020 - DS Smith, the world's leading supplier of corrugated cardboard, which focuses on creating innovative sustainable packaging solutions in more than 37 countries, has launched solidarity initiatives in all its markets to help mitigate the effects of Covid-19.
Aptar Pharma Partners with Lupin to Launch India’s First Connected Smart Device for Respiratory Disease, ADHERO
Inhalers are the preferred treatment option for managing the rising incidence of chronic respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) in India. However, it is estimated that nearly 45 percent of patients do not adhere to their therapy, including the filling and refilling of prescriptions or maintaining the prescribed medication schedule. This inconsistent adherence adversely impacts clinical outcomes and the patient’s quality-of-life. This new device, ADHERO, is designed to improve patient adherence to therapy.
ADHERO is a bluetooth-enabled, reusable smart device that attaches to the top of an MDI. With built-in sensors, the device tracks the patient’s daily medication usage and consumption patterns. Patients can access this information by connecting their ADHERO device to the “MyAdhero” app on their smartphones. The app is also equipped to send reminders, provide contextual health alerts based on factors like Air Quality Index at the patient’s current location and enable visual analytics. Patients can also grant their physician access to their information and medical tracking data through the dashboard portal as well as the app.
Aptar Pharma collaborated with Navia Life Care to develop the digital ecosystem for the MyAdhero App, which includes the Patient App, Care Provider App and the Doctor Portal.
Speaking about the launch, Rajeev Sibal, Lupin’s President India Region Formulations said, “Lupin lays great emphasis on three aspects of respiratory medicine, namely disease awareness, diagnosis and adherence. The launch of ADHERO will be a great help to patients using metered dose inhalers as well as for doctors to track adherence and compliance to therapy, thereby improving clinical outcomes and the quality-of-life of patients.”
Kanwal Tikoo, Aptar Pharma’s President of India & Southeast Asia commented, “We are pleased to have partnered with Lupin Limited on their ADHERO connected device program in India. With the steady rise in cases of asthma and COPD, this is an important step towards helping to improve adherence and health outcomes.”
Added Sai Shankar, Aptar Pharma’s Vice President, Global Digital Healthcare Systems, “Aptar Pharma has been building a portfolio of connected devices within the digital medicines ecosystem. We are focused on integrating services across device development and manufacturing, the digital platform experience and implementation with the healthcare stakeholders. We are excited about the first launch of a connected inhaler program for respiratory diseases in India with Lupin Limited.”
Connectivity: Add Value to Health Care
An “intelligent cap” makes the D-Flex smart: D-Flex Connect replaces the usual cap on the injection system, capturing and
collecting data and passing them on to the smartphone.
Learn more about Connected Solutions from Haselmeier in the attached pdf.
A pen for injecting one or more predefined dosage volumes.
It closes a gap in the market: The D-Flex injection pen can do more than previous pens. D-Flex can be configured for several
fixed dose values and is thus a variable fixed dose pen. It makes it possible to integrate a certain dosage value or several
different fixed dosage volumes in one injection device.
- INDUSTRY UPDATES
- OUR PRODUCTS
- Our Partners